L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm

Br J Haematol. 2013 Nov;163(4):543-5. doi: 10.1111/bjh.12523. Epub 2013 Aug 12.

Authors

Bérengère Gruson¹, Ioana Vaida, Lavinia Merlusca, Amandine Charbonnier, Anne Parcelier, Gandhi Damaj, Bruno Royer, Jean-Pierre Marolleau

Affiliation

¹ Clinical Haematology Department, Amiens University Hospital, Amiens, France.

PMID: 23937331
DOI: 10.1111/bjh.12523

No abstract available

Keywords: L-asparaginase; blastic plasmacytoid dendritic cell neoplasm; methotrexate; plasmacytoid dendritic cell.

Publication types

Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Asparaginase / administration & dosage
Asparaginase / adverse effects
Bone Marrow Neoplasms / drug therapy*
Dendritic Cells / pathology*
Dexamethasone / administration & dosage
Dexamethasone / adverse effects
Female
Humans
Male
Methotrexate / administration & dosage
Methotrexate / adverse effects
Middle Aged
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology

Substances

Dexamethasone
Asparaginase
Methotrexate